|
Volumn 36, Issue 12, 2013, Pages
|
Localized amyloidosis at the site of repeated insulin injection in a patient with type 2 diabetes
a
TENRI HOSPITAL
(Japan)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLUCOSE;
INSULIN DERIVATIVE;
INSULIN GLARGINE;
INSULIN LISPRO;
ISOPHANE INSULIN;
PREMIXED HUMAN INSULIN;
UNCLASSIFIED DRUG;
ANTIDIABETIC AGENT;
INSULIN;
AGED;
AMYLOIDOSIS;
BEDTIME DOSAGE;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
FEMALE;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HISTOPATHOLOGY;
HOSPITAL ADMISSION;
HUMAN;
HUMAN TISSUE;
INJECTION SITE;
INJECTION SITE AMYLOIDOSIS;
INJECTION SITE REACTION;
INSULIN RESISTANCE;
LABORATORY TEST;
LETTER;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHYSICAL EXAMINATION;
SUBCUTANEOUS TISSUE TUMOR;
TREATMENT DURATION;
WEIGHT GAIN;
ABDOMINAL WALL;
ADVERSE EFFECTS;
BIOPSY;
CHEMICALLY INDUCED;
DIABETES MELLITUS, TYPE 2;
DIFFERENTIAL DIAGNOSIS;
SKIN DISEASES;
SUBCUTANEOUS DRUG ADMINISTRATION;
ABDOMINAL WALL;
AGED;
AMYLOIDOSIS;
BIOPSY;
DIABETES MELLITUS, TYPE 2;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INJECTIONS, SUBCUTANEOUS;
INSULIN;
SKIN DISEASES;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 84891886808
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc13-1651 Document Type: Letter |
Times cited : (51)
|
References (3)
|